Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel.

Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel.

Bibliographic Details
Main Authors:	Qian Li, Mei Liu, Fei Ma, Yang Luo, Ruigang Cai, Liming Wang, Ningzhi Xu, Binghe Xu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4549142?pdf=render

Similar Items

Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.
by: Qian Li, et al.
Published: (2014-01-01)

Association between Lymph Node Status and Expression Levels of Androgen Receptor, miR-185, miR-205, and miR-21 in Breast Cancer Subtypes
by: Tatiana S. Kalinina, et al.
Published: (2020-01-01)

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
by: Nina Dusílková, et al.
Published: (2017-10-01)

MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer.
by: Annette Eyking, et al.
Published: (2016-01-01)

Alterations in the Expression Profile of Serum miR-155, miR-223, miR-17, miR-200a, miR-205, as well as Levels of Interleukin 6, and Prostaglandins during Endometritis in Arabian Mares
by: Sally Ibrahim, et al.
Published: (2021-06-01)

miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.
by: Kinya Okamoto, et al.
Published: (2013-01-01)

miR-205 in Breast Cancer: State of the Art
by: Ilaria Plantamura, et al.
Published: (2021-12-01)

Prognostic significance of miR-205 in endometrial cancer.
by: Mihriban Karaayvaz, et al.
Published: (2012-01-01)

Role of miR-205 in Breast Cancer Development
by: Beldiman, Cornelia
Published: (2014)

MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214.
by: Anvesha Srivastava, et al.
Published: (2013-01-01)

LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205
by: Wenwu Yang, et al.
Published: (2017-06-01)

Untersuchungen zur Funktion und Expression von miR-205 und miR-221 im Prostatakarzinom unter besonderer Beachtung von miR-205 als Prognosemarker beim Hochrisiko-Patienten
by: Kalogirou, Charis Alexis Thomas
Published: (2012)

Expression patterns and prognostic value of miR-210, miR-494, and miR-205 in middle-aged and old patients with sepsis-induced acute kidney injury
by: Yongjun Lin, et al.
Published: (2019-04-01)

miR-205: A Potential Biomedicine for Cancer Therapy
by: Neeraj Chauhan, et al.
Published: (2020-08-01)

MiR-205 Dysregulations in Breast Cancer: The Complexity and Opportunities
by: Yajuan Xiao, et al.
Published: (2019-11-01)

Hepatitis B Virus X Protein Inhibits Tumor Suppressor miR-205 through Inducing Hypermethylation of miR-205 Promoter to Enhance Carcinogenesis
by: Tao Zhang, et al.
Published: (2013-11-01)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
by: Schee Kristina, et al.
Published: (2012-11-01)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)

A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells.
by: Ketan S Patil, et al.
Published: (2015-01-01)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
by: Pan Lu, et al.
Published: (2017-01-01)

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.
by: Kristoffer Unterbruner, et al.
Published: (2018-01-01)

miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT
by: Bin Wang, et al.
Published: (2016-01-01)

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
by: Romero-Lorca A, et al.
Published: (2021-09-01)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
by: Elena Coccia, et al.
Published: (2020-12-01)

Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
by: Parisa Naeli, et al.
Published: (2017-11-01)

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
by: Oshrat Hershkovitz Rokah, et al.
Published: (2012-01-01)

Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors
by: Abbas Mosapour, et al.
Published: (2020-08-01)

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
by: Francesca Fornari, et al.
Published: (2015-01-01)

Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
by: Peter McAnena, et al.
Published: (2019-05-01)

Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer
by: Jia Yang, et al.
Published: (2021-09-01)

Methylation of <it>miR-34a, miR-34b/c</it>, <it>miR-124-1 </it>and <it>miR-203 </it>in Ph-negative myeloproliferative neoplasms
by: Chim Chor Sang, et al.
Published: (2011-11-01)

Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic Brucellosis
by: Ferah Budak, et al.
Published: (2016-01-01)

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
by: Uney James B, et al.
Published: (2011-06-01)

Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.
by: Xi Zeng, et al.
Published: (2012-01-01)

Expression of miR-127, miR-154, and miR-183 in Medullary Thy-roid Carcinoma Tumors
by: Mahsa RAHMANI SAMANI, et al.
Published: (2021-02-01)

Identification of putative target genes of miR-106b, miR-93, miR-25 in medulloblastoma.
Published: (2011)

MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
by: Dorota Jesionek-Kupnicka, et al.
Published: (2017-07-01)

miR-126 and miR-126*: New Players in Cancer
by: Jeannette Meister, et al.
Published: (2010-01-01)

Role of miR-503 and miR-144 in Distraction Osteogenesis
Published: (2016)